The DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
Open accessAbstract
A molecular basis for memory failure in Alzheimer's disease (AD) has been recently hypothesized, in which a significant role is attributed to small, soluble oligomers of amyloid beta-peptide (A beta). A beta oligomeric ligands (also known as ADDLs) are known to be potent inhibitors of hippocampal long-term potentiation, which is a paradigm for synaptic plasticity, and have been linked to synapse loss and reversible memory failure in transgenic mouse AD models. If such oligomers were to build up in human brain, their neurological impact could provide the missing link that accounts for the poor correlation between AD dementia and amyloid plaques. This article, using antibodies raised against synthetic A beta oligomers, verifies the predicted accumulation of soluble oligomers in AD frontal cortex. Oligomers in AD reach levels up to 70-fold over control brains. Brain-derived and synthetic oligomers show structural equivalence with respect to mass, isoelectric point, and recognition by conformation-sensitive antibodies. Both oligomers, moreover, exhibit the same striking patterns of attachment to cultured hippocampal neurons, binding on dendrite surfaces in small clusters with ligand-like specificity. Binding assays using solubilized membranes show oligomers to be high-affinity ligands for a small number of nonabundant proteins. Current results confirm the prediction that soluble oligomeric A beta ligands are intrinsic to AD pathology, and validate their use in new approaches to therapeutic AD drugs and vaccines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [11]
In the citing paper
“However, recent in vivo studies have shown that the soluble Aβ oligomers are possibly more neurotoxic than amyloid plaques,14–17 and are likely responsible for synaptic dysfunction and memory loss in AD patients and AD animal models.18–21”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [18]
In the citing paper
“which was also shown to form neurotoxic soluble Aβ oligomers.18–20”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [18]
In the citing paper
“recent studies have shown that the soluble Aβ oligomers are more neurotoxic both in vitro and in vivo.5−8”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [8]
In the citing paper
“the Aβ42 peptide was employed in these studies because it was shown to form neurotoxic soluble Aβ oligomers.5,8,48”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [8]
In the citing paper
“Dot immunoblots of soluble extracts from human brain show major increases in oligomers in AD-affected tissue (Gong et al., 2003; Kayed et al., 2003; Lambert et al., 2001).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Gong et al., 2003
In the citing paper
“as have the related predictions that oligomers cause dysfunctional trafficking of ionotropic glutamate receptors and metabotropic glutamate receptors (Gong et al., 2003; Lacor et al., 2004).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Gong et al., 2003
In the citing paper
“Cultured hippocampal neurons incubated with brain-derived oligomers show patterns that recapitulate the in situ distribution (Gong et al., 2003).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Gong et al., 2003
In the citing paper
“Because Arc is an actin binding protein, its aberrant expression was predicted to disrupt receptor trafficking (Lacor et al., 2004), which could consequently disrupt plasticity (Gong et al., 2003).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Gong et al., 2003
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citation
Research works printed but not linked: 2
- Terry R. D. (1999) in Alzheimer Disease eds. Terry R. D. Katzman R. Bick K. L. & Sisodia S. S. (Lippincott Williams & Wilkins Philadelphia) pp. 187-206.
- Chang L. Gong Y. Bakhos L. Yu J. Venton D. L. & Klein W. L. (2003) J. Mol. Neurosci. in press.
Cited by
Sorted by citations
Items 701–800 of 1,000
Assessing the Effects of Acute Amyloid β Oligomer Exposure in the Rat
Wong, R., Cechetto, D. F., & Whitehead, S. N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091390 · Cited by 19
Structural polymorphism and cytotoxicity of brain‐derived β‐amyloid extracts
Adem, K. A., & Lee, S.-M. (2023) · Protein Science · doi:10.1002/pro.4639 · Cited by 14
The sea urchin embryo: A model to study Alzheimer’s beta amyloid induced toxicity
Pellicano, M., Picone, P., Cavalieri, V., Carrotta, R., Spinelli, G., & Carlo, M. D. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.006 · Cited by 18
Oil Palm Phenolics Inhibit theIn VitroAggregation ofβ-Amyloid Peptide into Oligomeric Complexes
Weinberg, R. P., Koledova, V. V., Shin, H., Park, J. H., Tan, Y., Sinskey, A. J., Sambanthamurthi, R., & Rha, C. (2018) · International Journal of Alzheimer s Disease · doi:10.1155/2018/7608038 · Cited by 18
Malik, R., Di, J., Nair, G., Attar, A., Taylor, K. M., Teng, E., Klärner, F., Schrader, T. H., & Bitan, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7811-3_24 · Cited by 18
Jeong, D., Kim, J., Chae, M.-S., Lee, W., Yang, S.-H., Kim, Y., Kim, S., Lee, J., Lee, J., Choi, J., et al. (2018) · Italian National Conference on Sensors · doi:10.3390/s18061738 · Cited by 19
Dutta, S., Foley, A. R., Warner, C. J. A., Zhang, X., Rolandi, M., Abrams, B. S., & Raskatov, J. A. (2017) · Angewandte Chemie · doi:10.1002/ange.201706279 · Cited by 18
Han, F., Xu, H., Shen, J.-X., Pan, C., Yu, Z.-H., Chen, J.-J., Zhu, X.-L., Cai, Y.-F., & Lu, Y.-P. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-021 · Cited by 18
Wakeman, D. R., Weed, M. R., Perez, S. E., Cline, E. N., Viola, K. L., Wilcox, K. C., Moddrelle, D. S., Nisbett, E. Z., Kurian, A., Bell, A., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12800 · Cited by 18
Self-citationJin, H. K., Bae, J., Furuya, S., & Carter, J. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00625.x · Cited by 19
Roy, A., Chandra, K., Dolui, S., & Maiti, N. C. (2017) · ACS Omega · doi:10.1021/acsomega.7b00522 · Cited by 18
Joerchel, S., Raap, M., Bigl, M., Eschrich, K., & Schliebs, R. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.01.004 · Cited by 19
HtrA2 Interacts with Aβ Peptide but Does Not Directly Alter Its Production or Degradation
Liu, M.-L., Liu, M., Kim, J., Kim, H., Kim, J.-H., & Hong, S. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13202-x · Cited by 18
Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18
Xu, Y., Cao, D.-H., Wu, G., & Hou, X. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.05.011 · Cited by 17
Quantitation and Mapping of Cerebral Detergent‐Insoluble Proteins in the Elderly
Woltjer, R. L., Sonnen, J. A., Sokal, I., Rung, L. G., Yang, W. J., Kjerulf, J. D., Klingert, D., Johnson, C., Rhew, I. C., Tsuang, D. W., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00190.x · Cited by 17
Amyloid Oligomer Structures and Toxicity
Glabe, C. G. (2009) · The Open Biology Journal · doi:10.2174/1874196700902010222 · Cited by 18
Terol, P. A., Kumita, J. R., Hook, S., Dobson, C. M., & Esbjörner, E. K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.018 · Cited by 18
Axelsen, T. V., Holm, A., Christiansen, G., & Birkelund, S. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.026 · Cited by 17
Development of photocrosslinked sialic acid containing polymers for use in Aβ toxicity attenuation
Cowan, C. B., Coté, G. L., & Good, T. A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.001 · Cited by 17
Varshavskaya, K. B., Mitkevich, V. A., Makarov, A. А., & Barykin, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315036 · Cited by 18
Lagatta, D. C., Fassini, A., Terzian, A. L. B., Corrêa, F. M. D. A., & Resstel, L. B. M. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02786-5 · Cited by 16
Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
Yang, Y., Giau, V. V., An, S. S. A., & Kim, S. (2018) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2018.17.2.41 · Cited by 16
Gupta, S. N., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666181114163515 · Cited by 16
Wu, S., Zhang, J., Jiang, C., Wang, S., Que, R., & An, L. (2020) · Food & Function · doi:10.1039/d0fo00161a · Cited by 16
Bitencourt, A. L. B., de Campos, R. M., Cline, E. N., Klein, W. L., & Sebollela, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238920 · Cited by 18
Self-citationEffect of amyloid β on capacitive calcium entry in neural 2a cells
Niu, Y., Su, Z., Zhao, C., Song, B., Zhang, X., Zhao, N., Shen, X., & Gong, Y. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.10.003 · Cited by 16
Self-citationBarr, R. K., Verdile, G., Wijaya, L. K., Morici, M., Taddei, K., Gupta, V. B., Pedrini, S., Jin, L., Nicolazzo, J. A., Knock, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679993 · Cited by 16
Synthetic toxic Aβ 1–42 oligomers can assemble in different morphologies
Bobo, C., Chaignepain, S., Henry, S., Vignaud, H., Améadan, A., Marchal, C., Prado, É., Doutch, J., Schmitter, J., Nardin, C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.03.001 · Cited by 16
Nováková, J., Mikasová, L., Machová, E., Lisá, V., & Doležal, V. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.021 · Cited by 16
Lin, H., Chung, C., Chen, L., Wang, J., Chen, C., Huang, K., Tsai, M.-H., Chien, W., & Lin, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-33674-2 · Cited by 17
Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
Heuer, S. E., Bloss, E. B., & Howell, G. R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109987 · Cited by 16
Binding of Inositol Stereoisomers To Model Amyloidogenic Peptides
Li, G., Rauscher, S., Baud, S., & Pomès, R. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp208567n · Cited by 15
Simple model systems: a challenge for Alzheimer's disease
Carlo, M. D. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-3 · Cited by 17
Löffler, T., Flunkert, S., Havas, D., Schweinzer, C., Uger, M. D., Windisch, M., Steyrer, E., & Hutter‐Paier, B. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-84 · Cited by 15
Wang, X., Zhang, S., Li, Y., & Zhang, Y. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae154 · Cited by 14
Arslan, P. E., Mulligan, V. K., Ho, S., & Chakrabartty, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.12.019 · Cited by 14
Anchored FRET sensors detect local caspase activation prior to neuronal degeneration
Figueroa, R. A., Ramberg, V., Gatsinzi, T., Samuelsson, M., Zhang, M., Iverfeldt, K., & Hallberg, E. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-35 · Cited by 14
Chan, H. H., Koh, R. Y., Lim, C. L., & Leong, C. O. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191023102422 · Cited by 15
Alves, S. S., da Silva-Júnior, R. M. P., Delfino-Pereira, P., Pereira, M. G. A. G., Vasconcelos, I. C., Schwaemmle, H., Mazzei, R. F., Carlos, M. L., Espreáfico, E. M., Tedesco, A. C., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02810-w · Cited by 14
Internalized Amyloid-β (1-42) Peptide Inhibits the Store-Operated Calcium Entry in HT-22 Cells
Poejo, J., Orantos-Aguilera, Y., Martı́n-Romero, F. J., Mata, A. M., & Gutiérrez‐Merino, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012678 · Cited by 14
Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy
Dupiereux-Fettweis, I., Zorzi, W., Quadrio, I., Perret‐Liaudet, A., Kovács, G. G., Heinen, E., & Elmoualij, B. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152409787601950 · Cited by 16
Liu, Y., Gao, Y., Li, K., & Xue, W. (2018) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2018.1540596 · Cited by 14
Bartley, S. C., Proctor, M. T., Xia, H., Ho, E., Kang, D. S., Schuster, K. H., Bicca, M. A., Seckler, H. S., Viola, K. L., Patrie, S. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042208 · Cited by 14
Self-citationKuhn, A. J., Chan, K., Sajimon, M., Yoo, S., Serrão, V. H. B., Lee, J., Abrams, B. S., Nowick, J. S., Uversky, V. N., Wheeler, C. J., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c11511 · Cited by 14
Laras, Y., Pietrancosta, N., Tomita, T., Iwatsubo, T., & Kraus, J. L. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701832706 · Cited by 13
Savioz, A., Giannakopoulos, P., Herrmann, F. R., Klein, W. L., Kövari, E., Bouras, C., & Giacobini, E. (2016) · Neurodegenerative Diseases · doi:10.1159/000446283 · Cited by 14
Self-citationBernardo, M. D., & Carlo, M. D. (2017) · InTech eBooks · doi:10.5772/intechopen.70301 · Cited by 13
Functional Amyloids and their Possible Influence on Alzheimer Disease
Lau, A., Bourkas, M. E. C., Lu, Y. Q. Q., Ostrowski, L., Weber‐Adrian, D., Figueiredo, C., Arshad, H., Shoaei, S. Z. S., Morrone, C. D., Matan‐Lithwick, S. A., et al. (2017) · Discoveries · doi:10.15190/d.2017.9 · Cited by 13
Zhao, L., Chen, M.-W., Qian, Y., Yang, Q., Ge, Y., Chen, H., & Qiu, Y. L. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.007 · Cited by 13
Grasso, G., Lionello, C., & Stojceski, F. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107670 · Cited by 13
Yanagisawa, D., Ibrahim, N. F., Taguchi, H., Morikawa, S., Tomiyama, T., & Tooyama, I. (2021) · Molecules · doi:10.3390/molecules26051362 · Cited by 13
The nucleation growth and reversibility of Amyloid-β deposition in vivo
Dolev, I., & Michaelson, D. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-313 · Cited by 13
Development of vaccination approaches for the treatment of neurological diseases
Federoff, H. J. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22034 · Cited by 13
Soluble Oligomers of the Amyloid β-Protein: Impair Synaptic Plasticity and Behavior
Selkoe, D. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-76330-7_8 · Cited by 13
Alzheimer's amyloid immunotherapy: quo vadis?
Gandy, S., & Heppner, F. L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70124-1 · Cited by 13
Kim, J., & Yang, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1327886 · Cited by 13
Zhao, X., Zhang, R., Hu, D., Li, M., Liu, Y., Xiu, X., Jia, H., Wang, H., Li, Z., Liu, Y., et al. (2024) · Dyes and Pigments · doi:10.1016/j.dyepig.2024.111993 · Cited by 13
Randhawa, S., Dar, A. I., Saini, T. C., Bathla, M., & Acharya, A. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102243 · Cited by 12
Modeling Amyloid-Beta as Homogeneous Dodecamers and in Complex with Cellular Prion Protein
Gallion, S. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049375 · Cited by 14
The neurodegeneration in Alzheimer disease and the prion protein
Forloni, G., Sclip, A., Borsello, T., & Balducci, C. (2013) · Prion · doi:10.4161/pri.23286 · Cited by 13
Reduction of amyloid beta by Aβ3-10-KLH vaccine also decreases tau pathology in 3×Tg-AD mice
Zhang, H., Zhu, K., Meng, Y., Ding, L., Wang, J.-C., Yin, W., Yan, Y., & Cao, Y. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.07.019 · Cited by 13
Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
Ahn, K.-C., Learman, C. R., Baker, G. B., Weaver, C. L., Chung, P., Kim, H., & Song, M.-S. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e297 · Cited by 12
Matsubara, E., Takamura, A., Okamoto, Y., Oono, H., Nakata, T., Wakasaya, Y., Kawarabayashi, T., & Shoji, M. (2013) · BioMed Research International · doi:10.1155/2013/984041 · Cited by 12
Ohshima, Y., Taguchi, K., Mizuta, I., Tanaka, M., Tomiyama, T., Kametani, F., Yabe‐Nishimura, C., Mizuno, T., & Tokuda, T. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00511 · Cited by 12
Saha, J., Dean, D. N., Dhakal, S., Stockmal, K. A., Morgan, S. E., Dillon, K. D., Adamo, M. F., Levites, Y., & Rangachari, V. (2021) · The FASEB Journal · doi:10.1096/fj.202002025rr · Cited by 12
Nitrogen-appended N-alkylsulfonamides as inhibitors of γ-secretase
Bergstrom, C. P., Sloan, C. P., Wang, H. H., Parker, M. F., Smith, D. W., Zheng, M., Hansel, S. B., Polson, C. T., Barber, L. E., Bursuker, I., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.105 · Cited by 12
Modulators of Amyloid β-Protein (Aβ) Self-Assembly
Rahimi, F., Li, H. J., Sinha, S., & Bitan, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00006-x · Cited by 12
Conformational Stability of Aβ‐(25–35) in the Presence of Thiazolidine Derivatives
Campiglia, P., Esposito, C., Scrima, M., Gomez-Monterrey, I. M., Bertamino, A., Grieco, P., Novellino, E., & D’Ursi, A. M. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00482.x · Cited by 12
Takamura, A., Kawarabayashi, T., Yokoseki, T., Shibata, M. S., Morishima‐Kawashima, M., Saito, Y., Murayama, S., Ihara, Y., Abe, K., Shoji, M., et al. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22615 · Cited by 11
Actor-Engel, H. S., Schwartz, S. L., Crosby, K. C., Sinnen, B. L., Prikhodko, O., Ramsay, H. J., Bourne, J. N., Winborn, C. S., Lucas, A., Smith, K. R., et al. (2021) · eNeuro · doi:10.1523/eneuro.0416-21.2021 · Cited by 11
Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
Rådestig, M. A., Skoog, I. G., Skillbäck, T. B., Zetterberg, H., Kern, J., Zettergren, A., Andréasson, U., Wetterberg, H., Kern, S., & Blennow, K. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01193-x · Cited by 11
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
Haut, F., Argyrousi, E. K., & Arancio, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010259 · Cited by 11
Statistical Mechanics and Kinetics of Amyloid Fibrillation
Hong, L., Lee, C. F., & Huang, Y. J. (2017) · World Scientific lecture and course notes in chemistry · doi:10.1142/9789813202382_0004 · Cited by 11
Single gold bipyramids on a silanized substrate as robust plasmonic sensors for liquid environments
Rye, J.-M., Bonnet, C., Lerouge, F., Pellarin, M., Lermé, J., Parola, S., & Cottancin, E. (2018) · Nanoscale · doi:10.1039/c8nr03400a · Cited by 11
Jiang, H., Wan, Z., Ding, Y., & Yao, Z. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01781-8 · Cited by 11
Tweedie, D., Brossi, A. R., Chen, D., Ge, Y., Bailey, J. A., Yu, Q.-S., Kamal, M. A., Sambamurti, K., Lahiri, D. K., & Greig, N. H. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10102 · Cited by 11
Klein, W. L. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_4 · Cited by 11
Self-citationHou, Y., Yu, Y.-B., Liu, G.-T., & Luo, Y. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1133 · Cited by 11
A Computational Positron Emission Tomography Simulation Model for Imaging ?-Amyloid in Mice
Simmons, M. K., Manjeshwar, R. M., Agdeppa, E. D., Mattheyses, R. M., Kiehl, T. R., & Montalto, M. (2004) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0952-9 · Cited by 11
Chauhan, V. P. S., Sheikh, A. M., Chauhan, A., Spivack, W. D., Fenko, M. D., & Malik, M. N. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7105 · Cited by 11
Carbamate-appended N-alkylsulfonamides as inhibitors of γ-secretase
Bergstrom, C. P., Sloan, C. P., Lau, W.-Y., Smith, D. W., Zheng, M., Hansel, S. B., Polson, C. T., Corsa, J. A., Barten, D. M., Felsenstein, K. M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.102 · Cited by 11
Making Memories: Why Time Matters
Kelley, P., Evans, M. D. R., & Kelley, J. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00400 · Cited by 10
Spectroscopic detection of β ‐sheet structure in nascent Aβ oligomers
Wang, M., & JiJi, R. D. (2011) · Journal of Biophotonics · doi:10.1002/jbio.201100023 · Cited by 10
Mechanisms of Microglial Activation by Amyloid Precursor Protein and its Proteolytic Fragments
Austin, S. A., & Combs, C. K. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_2 · Cited by 10
Nonhuman Amyloid Oligomer Epitope Reduces Alzheimer’s-Like Neuropathology in 3xTg-AD Transgenic Mice
Rasool, S., Martínez‐Coria, H., Milton, S. C. F., & Glabe, C. G. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8478-7 · Cited by 10
α7-Nicotinic Acetylcholine Receptors: New Therapeutic Avenues in Alzheimer’s Disease
Öz, M., Petroianu, G. A., & Lorke, D. E. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_9 · Cited by 10
Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides
Pagni, G., Tagliarini, C., Carbone, M. G., Imbimbo, B. P., Marazziti, D., & Pomara, N. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210921164816 · Cited by 10
Specific recognition of the C-terminal end of Aβ42 by a high affinity monoclonal antibody
Axelsen, T. V., Holm, A., Birkelund, S., Christiansen, G., Ploug, M., & Holm, I. E. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.007 · Cited by 10
Wang, C.-M., deVries, S., Camboni, M., Glass, M., & Martin, P. T. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.013 · Cited by 10
Interactions of Amyloid β Peptide 1–40 and Cerebrosterol
Krištofíková, Z., Křı́ž, Z., Řı́pová, D., & Koča, J. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0650-8 · Cited by 10
Structure‐dependent effects of amyloid‐β on long‐term memory in Lymnaea stagnalis
Ford, L. K., Crossley, M., Vadukul, D. M., Kemenes, G., & Serpell, L. C. (2017) · FEBS Letters · doi:10.1002/1873-3468.12633 · Cited by 10
Amyloid Fibril Design: Limiting Structural Polymorphism in Alzheimer’s Aβ Protofilaments
Bartłomiej, T., Yuan, Y., McCartan, S., Szydłowska, B. M., Tofoleanu, F., Brooks, B. R., & Buchete, N. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b07423 · Cited by 12
Lana, E., Gellerbring, A., Jung, S., Nordberg, A. K., Lithner, C. U., & Darreh‐Shori, T. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00176 · Cited by 10
Therapeutic Approaches to Delay the Onset of Alzheimer's Disease
Kumar, R., & Atamna, H. (2011) · Journal of Aging Research · doi:10.4061/2011/820903 · Cited by 10
Alzheimer's disease protein Aβ1–42 does not disrupt isolated synaptic vesicles
Allen, P. B., & Chiu, D. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.02.002 · Cited by 10
Brain region-specific myelinogenesis is not directly linked to amyloid-β in APP/PS1 transgenic mice
Wu, S.-L., Yu, B., Cheng, Y.-J., Ren, S.-Y., Wang, F., Xiao, L., Chen, J., & Mei, F. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114344 · Cited by 9
EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure
Jang, C., Barron, D. P., Duo, L., Ma, C., Seabaugh, H., & Guo, Z. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00364 · Cited by 9
SorCS1 inhibits amyloid-β binding to neurexin and rescues amyloid-β–induced synaptic pathology
Lee, A. K., Yi, N., Khaled, H., Feller, B., Chofflet, N., & Takahashi, H. (2023) · Life Science Alliance · doi:10.26508/lsa.202201681 · Cited by 11
Alzheimer's Factors in Ischemic Brain Injury
Pluta, R. M., & Jaboski, M. (2012) · InTech eBooks · doi:10.5772/27205 · Cited by 9
Metadata
- Authors
- Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-08-18
- Volume
- 100
- Issue
- 18
- Pages
- 10417-10422
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC193576
- OpenAlex
- W2040721710
- Cited by
- 1,061
- References
- 55
- Citations by year
- 2026: 21 · 2025: 15 · 2024: 19 · 2023: 32 · 2022: 24 · 2021: 33 · 2020: 35 · 2019: 38 · 2018: 44 · 2017: 45 · 2016: 32 · 2015: 42 · 2014: 52 · 2013: 49 · 2012: 53
- FWCI
- 35.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health (1p01ag015501-01)
- National Institute on Aging (P01-AG15501, R01-AG18877, R01AG018877)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta oligomers, memory loss, hippocampal long-term potentiation, synaptic plasticity, synaptic loss, frontal cortex, dendrites, protein-ligand binding, amyloid plaques, therapeutic vaccines
- MeSH terms
- Alzheimer Disease, Animals, Binding Sites, Brain Chemistry, Cells, Cultured, Cerebral Cortex, Ligands, Neurons, Oligopeptides, Peptide Fragments, Tissue Extracts, Immunoblotting, Amyloid beta-Peptides, Rats, Sprague-Dawley, Long-Term Potentiation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
